References
- Nicolau DP. Current challenges in the management of the infected patient. Curr Opin Infect Dis. 2011;24:1–10.
- Wilke MH. Multiresistant bacteria and current therapy – the economical side of the story. Eur J Med Res. 2010;15:571–576.
- Gniadkowski M. Evolution of extended spectrum beta-lactamases by mutation. Clin Microbiol Infect. 2008;14:11–32.
- Bush K. Alarming beta-lactamase mediated resistance in multidrug-resistant Enterobacteriaceae. Curr Opin Microbiol. 2010;13:558–564.
- O’Callaghan CH. Structure activity relations and beta-lactamase resistance. Philos Trans R Soc Lond B. 1980;289:197–205.
- Fircanis S, McKay M. Recognition and management of extended spectrum beta lactamase producing organisms (ESBL). Med Health R I. 2010;93:161–162.
- Frezza M, Garay J, Chen D, Cui C, Turos E, Dou QP. Induction of tumor cell apoptosis by a novel class of N-thiolated beta-lactam antibiotics with structural modifications at N1 and C3 of the lactam ring. Int J Mol Med. 2008;21:689–695.
- Neu HC. Relation of structural properties of beta-lactam antibiotics to antibacterial activity. Am J Med. 1985;79:2–13.
- Karunaratne DN, Farmer S, Hancock RE. Synthesis of bulky beta lactams for inhibition of cell surface beta-lactamase activity. Bioconjug Chem. 1993;4:434–439.
- Abeylath SC, Turos E, Dickey S, Lim DV. Glyconanobiotics: novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis. Bioorg Med Chem. 2008;16:2412–2418.
- Turos E, Shim JY, Wang Y, Greenhalgh K, Reddy GS, Dickey S. Antibiotic-conjugated polyacrylate nanoparticles: new opportunities for development of anti-MRSA agents. Bioorg Med Chem Lett. 2007;17:53–56.
- Paszko E, Ehrhardt C, Senge MO, Kelleher DP, Reynolds JV. Nanodrug applications in photodynamic therapy. Photodiag Photodyn Ther. 2011;8:14–22.
- Raad II, Mohamed JA, Reitzel RA, Jiang Y, Dvorak TL, Ghannoum MA, Hachem RY, Chaftari AM. The prevention of biofilm colonization by multidrug resistant pathogens that cause ventilator associated pneumonia with antimicrobial coated endotracheal tubes. Biomaterials. 2011;32:2689–2694.
- Avasthi DK, Mishra YK, Singhal R, Kabiraj D, Mohapatra S, Mohanta B. Synthesis of plasmonic nanocomposites for diverse applications. J Nanosci Nanotechnol. 2010;10:2705–2712.
- Taylor EN, Webster TJ. The use of superparamagnetic nanoparticles for prosthetic biofilm prevention. Int J Nanomedicine. 2009;4:145–152.
- Diao M, Yao M. Use of zero-valent iron nanoparticles in inactivating microbes. Water Res. 2009;43:5243–5251.
- Chen WJ, Tsai PJ, Chen YC. Functional Fe3O4/TiO2 core/shell magnetic nanoparticles as photokilling agents for pathogenic bacteria. Small. 2008;4:485–491.
- Gu H, Ho PL, Tsang KW, Wang L, Xu B. Using biofunctional magnetic nanoparticles to capture vancomycin-resistant enterococci and other gram positive bacteria at ultralow concentration. J Am Chem Soc. 2003;125:15702–15703.
- Tran N, Mir A, Mallik D, Sinha A, Nayar S, Webster TJ. Bactericidal effect of iron oxide nanoparticles on Staphylococcus aureus. Int J Nanomedicine. 2010;5:277–283.
- Li X, Li X. Oxidative polymerization of aniline using NaClO2 as an oxidant. Mater Lett. 2007;61:2011–2014.
- Dey S, Coudhary R, Vaithiyanathan S, Samal HB, Reddy YV, Krishna B. Spectrophotometric method developed for the estimation of flucloxacilin in bulk and dosage form using UV-Vis spectrophotometric method. Int J Pharma Bio Sci. 2010;1:35–43.
- Kachalova AV, Stetsenko DA, Gait MJ, Oretskaya TS. Synthesis of oligonucleotide 2′-conjugates via amide bond formation in solution. Bioorg Med Chem Lett. 2004;14:801–804.
- Turos E, Reddy GSK, Greenhalgh K, Ramaraju P, Abeylath SC, Jang S, Dickey S and Lim DV. Penicillin-bound polyacrylate nanoparticles: restoring the activity of b-lactam antibiotics against MRSA. Bioorg Med Chem Lett. 2007;17:3468–3472.